Pharma Pulse 9/16/24: Copay Adjustment Chess Match, Alzheimer Drug Pipeline Expands & more

Copay Adjustment Chess Match: What Will Payers Do Next?

As new litigation looms in the debate over use of copay accumulator programs, a look at potential next moves for payers—and steps drug manufacturers should take to ward off cost-driven non-adherence.

Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development

The Alzheimer disease treatment landscape is evolving with new FDA-approved antibody therapies and advancements in biomarker testing to enable earlier diagnosis and intervention.

Hopeful News for Users of One A.D.H.D. Drug

The D.E.A. is increasing its quota for Vyvanse as patients still struggle to fill prescriptions.

Advanced eClinical Training Partners with The Education Fund to Expand Educational Opportunities for Healthcare Workers

This collaboration provides union healthcare workers with access to high-demand Allied Health certifications through short-term online and blended programs.

Pharmaceutical Executive on LinkedIn
Tickets are now on sale for the 2024 Pharmaceutical Executive® APEX Awards!

Get ready for an unforgettable night at the New York Hilton Midtown, NYC on November 13! Don't miss out — be part of a night honoring the best in healthcare marketing.

Grab your tickets today: https://ow.ly/Nm4p50TljT8

#PharmaMarketing #HealthcareMarketing #PEAPEXAwards

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs